Showing results (21-30 of 78) with videos related to
Sort By:
Pageof 8
Cancer Immunology, Immunotherapy : CII|September 4, 2020
Increased thyroid uptake on 18F-FDG PET/CT is associated with the development of permanent hypothyroidism in stage IV melanoma patients treated with anti-PD-1 antibodiesAlexandra Frelau, Xavier Palard-Novello, Eva Jali, et al.Cancer Chemotherapy and Pharmacology|June 16, 2012
Population pharmacokinetic/pharmacodynamic modeling of drug-induced adverse effects of a novel homocamptothecin analog, elomotecan (BN80927), in a Phase I dose finding study in patients with advanced solid tumorsIñaki F Trocóniz, Josep-María Cendrós, Elena Soto, et al.The Journal of Dermatological Treatment|May 29, 2012
Metastatic melanoma: results of 'classical' second-line treatment with cytotoxic chemotherapiesChristophe Perrin, Marc Pracht, Karen Talour, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2010
Large randomized study of thymosin alpha 1, interferon alfa, or both in combination with dacarbazine in patients with metastatic melanomaMichele Maio, Andrzej Mackiewicz, Alessandro Testori, et al.Pigment Cell & Melanoma Research|November 10, 2009
ERK-regulated differential expression of the Mitf 6a/b splicing isoforms in melanomaAline Primot, Ariane Mogha, Sébastien Corre, et al.Cancer Investigation|July 7, 2007
Impact of PET-FDG in the diagnosis and therapeutic care of patients presenting with metastases of unknown primaryEtienne Garin, Florence Prigent-Lejeune, Thierry Lesimple, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2011
A 4-gene signature associated with clinical outcome in high-grade gliomasMarie de Tayrac, Marc Aubry, Stephan Saïkali, et al.Journal of the National Cancer Institute|March 7, 2022
The Association Between Antibiotic Use and Outcome Among Metastatic Melanoma Patients Receiving ImmunotherapyFlorence Poizeau, Sandrine Kerbrat, Frédéric Balusson, et al.Journal of Neuro-Oncology|January 14, 2009
Topotecan in combination with radiotherapy in unresectable glioblastoma: a phase 2 studyThierry Lesimple, Laurent Riffaud, Didier Frappaz, et al.Cancer|February 2, 2012
Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, MethyLight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of 100 glioblastoma patientsVéronique Quillien, Audrey Lavenu, Lucie Karayan-Tapon, et al.Pageof 8